Enjoy complimentary customisation on priority with our Enterprise License!
The Global Influenza Diagnostics Market size is forecast to increase by USD 517.5 million at a CAGR of 7.22% between 2023 and 2028. Market expansion hinges on several key factors, notably the increasing incidence of influenza, which drives the demand. As the prevalence of infectious diseases rises, there's a corresponding need for advanced diagnostic tools capable of accurate and rapid detection. The growing adoption of molecular diagnostics, with its ability to identify specific pathogens and genetic markers, further propels market growth. Additionally, supportive government initiatives and funding play a crucial role in driving research, development, and accessibility of these diagnostic technologies. By fostering innovation and incentivizing healthcare providers to adopt advanced diagnostic solutions, governments contribute to the expansion of the market, ultimately leading to improved public health outcomes.
To learn more about this report, Request Free Sample
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.